Fundz

Ne Xt Gen Biologics, Inc reported raising $2.16 Million in an initial SEC Form D filing

PRIVATEDec 27, 2018

Amount Raised

$2.16 Million

$2.16 Million sold, per SEC Form D (first sale Dec 27, 2018)

Round Type

Seed

AlachuaBiotechnologymedical devices

Quick answer

NeXtGen Biologics raised $2.16 Million in a Seed round, dated December 27, 2018. NeXtGen Biologics is based in Alachua, Florida, United States.

How much did NeXtGen Biologics raise?
NeXtGen Biologics raised $2.16 Million in a Seed round on December 27, 2018.
What does NeXtGen Biologics do?
NeXtGen™ Biologics, Inc. is a medical device company that specializes in advanced biotechnology for regeneration and scar-free healing.
Where is NeXtGen Biologics based and how big is it?
NeXtGen Biologics is based in Alachua, Florida, United States. Fundz records about 20 employees.

Source: Fundz verified event record.

Who else raised in medical devices and Biotechnology around the same time

Companies in the same sectors as NeXtGen Biologics that raised within 45 days of this round, from Fundz verified event records.

  • Avita Medical raised $8.9M on December 19, 2018.
  • Xeno Biosciences raised $720K (Seed) on February 8, 2019.
  • Exact Imaging raised $7.6M on February 8, 2019.
  • SUNP INTERNATIONAL INC raised $4.3M (Seed) on February 8, 2019.
  • Mill Creek Life Sciences, LLC raised an undisclosed amount on February 7, 2019.
  • BIOCURITY PHARMACEUTICALS INC. raised $50K (Pre-Seed) on February 7, 2019.

Who to call at NeXtGen Biologics, and when

A new round usually means NeXtGen Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeXtGen Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeXtGen Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeXtGen Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeXtGen Biologics

Location

13709 PROGRESS BLVD. BOX 11

Alachua, Florida, United States

About

NeXtGen™ Biologics, Inc. is a medical device company that specializes in advanced biotechnology for regeneration and scar-free healing. The company has developed a portfolio of patents for its extracellular matrix (ECM) platform technology, which is derived from the axolotl, a salamander known for its remarkable regenerative abilities. NeXtGen uses this technology to create solutions for various medical conditions across specialties such as wound care, general surgery, trauma, plastic surgery, cardiovascular diseases, neurosurgery, orthopedics, and ophthalmology. The flagship product, NeoMatriX® Wound Matrix, is made from the dermal ECM of the axolotl. It is available in sheets of different sizes, designed to optimize the wound environment and promote healing for various wound types, including partial and full-thickness wounds and pressure ulcers. NeoMatriX is notable for being a room-temperature product that is readily available off-the-shelf, making it easy to use and cost-effective. NeXtGen is focused on expanding its infrastructure and increasing awareness of its products among healthcare professionals following FDA clearance for NeoMatriX in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeXtGen Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NeXtGen Biologics's next move

See what Strategic adds

NeXtGen Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.